Tomohiro Nishina - Department of Internal Medicine, National Shikoku Cancer Center

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 283 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Table S4 from A Phase II Placebo-Controlled Study of the Effect and Safety of Nanvuranlat in Patients with Advanced Biliary Tract Cancers Previously Treated by Systemic Chemotherapy

Junji Furuse,Masafumi Ikeda,Makoto Ueno,Masayuki Furukawa,Chigusa Morizane,Tetsuo Takehara,Tomohiro Nishina,Akiko Todaka,Naohiro Okano,Kazuo Hara,Yousuke Nakai,Kazuyoshi Ohkawa,Takashi Sasaki,Kazuya Sugimori,Naoyuki Yokoyama,Kouji Yamamoto

crossref（2024）

Cited0Views0Bibtex

Supplementary Table S7 from A Phase II Placebo-Controlled Study of the Effect and Safety of Nanvuranlat in Patients with Advanced Biliary Tract Cancers Previously Treated by Systemic Chemotherapy

crossref（2024）

Cited0Views0Bibtex

Novel ERBB2 Variant Potentially Associated with Resistance Against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal Cancer

Clinical cancer research an official journal of the American Association for Cancer Researchno. 18 (2024): 4167-4178

Cited0Views0WOSBibtex

Deciphering Tumor Microenvironment Dynamics in HER2-amplified Refractory Metastatic Colorectal Cancer in the TRIUMPH Trial

Mitsuho Imai,Jinyeong Lim, Naoko Iida,Hiromichi Ebi,Wataru Okamoto,Takeshi Kato, Taito Esaki,Ken Kato,Yoshito Komatsu,Satoshi Yuki,Toshiki Masuishi,Tomohiro Nishina,Akihiro Sato, Riu Yamashita, Satoshi Fujii,Takayuki Yoshino, Woong-Yang Park, Yoshiaki Nakamura

Journal of Clinical Oncologyno. 16_suppl (2024): 3564-3564

Cited0Views0Bibtex

Trastuzumab Deruxtecan in Advanced Solid Tumors with Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial

Masataka Yagisawa,Hiroya Taniguchi,Taroh Satoh,Shigenori Kadowaki,Yu Sunakawa,Tomohiro Nishina,Yoshito Komatsu,Taito Esaki,Daisuke Sakai,Ayako Doi,Takeshi Kajiwara,Hiromi Ono, Masatoshi Asano,Nami Hirano,Justin Odegaard, Satoshi Fujii,Shogo Nomura,Hideaki Bando,Akihiro Sato,Takayuki Yoshino,Yoshiaki Nakamura

Journal of clinical oncology official journal of the American Society of Clinical Oncologyno. 32 (2024): 3817-3825

Cited0Views0WOSBibtex

Supplementary Figure S3 from A Phase II Placebo-Controlled Study of the Effect and Safety of Nanvuranlat in Patients with Advanced Biliary Tract Cancers Previously Treated by Systemic Chemotherapy

crossref（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn